Myovant Sciences
-
Sumitovant Biopharma Submits NDA to FDA for Relugolix Combination for Uterine Fibroids
NEW YORK and LONDON: Sumitovant Biopharma Ltd. has said that Myovant Sciences, one of five healthcare companies in the Sumitovant…
Read More »